Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CD | O00329 | 8/20 | 0.55 |
| ▸ | PIK3CB | P42338 | 7/20 | 0.55 |
| ▸ | PIK3CG | P48736 | 6/20 | 0.55 |
| ▸ | PIK3CA | P42336 | 4/20 | 0.55 |
| ▸ | PIM1 | P11309 | 2/20 | 0.48 |
| ▸ | GSK3B | P49841 | 2/20 | 0.48 |
| ▸ | METTL3 | Q86U44 | 1/20 | 0.39 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.35 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.35 |
| ▸ | ARHGDIA | P52565 | 1/20 | 0.35 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.35 |
| ▸ | METAP2 | P50579 | 1/20 | 0.34 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.34 |
| ▸ | BRD4 | O60885 | 1/20 | 0.34 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.34 |
| ▸ | ATR | Q13535 | 1/20 | 0.34 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.33 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.33 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10187671 | 1.00 | PIK3CD (0.55) | PIK3CDPIK3CBPIK3CGPIK3CAPIM1 | |
| SCHEMBL717275 | 1.00 | PIK3CD (0.55) | PIK3CDPIK3CBPIK3CGPIK3CAPIM1 | |
| SCHEMBL716079 | 0.90 | PIK3CD (0.55) | PIK3CDPIK3CBPIK3CGPIK3CAPIM1 | |
| SCHEMBL715105 | 0.85 | PIK3CG (0.71) | PIK3CDPIK3CBPIK3CGPIK3CAPIM1 | |
| SCHEMBL715583 | 0.84 | PIK3CD (0.57) | PIK3CDPIK3CBPIK3CGPIK3CAPIM1 | |
| SCHEMBL715632 | 0.84 | PIK3CD (0.56) | PIK3CDPIK3CBPIK3CGPIK3CAPIM1 | |
| SCHEMBL715633 | 0.84 | PIK3CD (0.56) | PIK3CDPIK3CBPIK3CGPIK3CAPIM1 | |
| SCHEMBL457718 | 0.84 | PIK3CD (0.63) | PIK3CDPIK3CBPIK3CGPIK3CAPIM1 | |
| SCHEMBL458073 | 0.84 | PIK3CD (0.54) | PIK3CDPIK3CBPIK3CGPIK3CAPIM1 | |
| SCHEMBL470334 | 0.84 | PIK3CD (0.51) | PIK3CDPIK3CBPIK3CGPIK3CAPIM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9326987-B2 | Indazole derivatives for use in the treatment of influenza virus infection | GLAXO GROUP LIMITED (GB) | 2016-05-03 | — | — | US | disclosed |
| EP-2406255-B1 | 4-OXADIAZOL-2-YL-INDAZOLES AS INHIBITORS OF PI3 KINASES | GLAXO GROUP LTD (GB) | 2015-04-29 | — | — | EP | disclosed |
| US-20130165433-A1 | Novel Use | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2013-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130165433-A1 | Novel Use | HAVCR2, MAVS, ENTPD5 | PIK3CD 2938/4885PIK3CB 1706/4885PIK3CG 2718/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.